AU1468792A - A composition comprising a peptide for nasal administration - Google Patents

A composition comprising a peptide for nasal administration

Info

Publication number
AU1468792A
AU1468792A AU14687/92A AU1468792A AU1468792A AU 1468792 A AU1468792 A AU 1468792A AU 14687/92 A AU14687/92 A AU 14687/92A AU 1468792 A AU1468792 A AU 1468792A AU 1468792 A AU1468792 A AU 1468792A
Authority
AU
Australia
Prior art keywords
peptide
composition
nasal administration
nasal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14687/92A
Other languages
English (en)
Inventor
Brigitte Smedemark Dath
Annie Rassing Hoelgaard
Linda Mindeholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU1468792A publication Critical patent/AU1468792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU14687/92A 1991-03-20 1992-03-18 A composition comprising a peptide for nasal administration Abandoned AU1468792A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK91497A DK49791D0 (da) 1991-03-20 1991-03-20 Nasalt pulverpraeparat
DK497/91 1991-03-20

Publications (1)

Publication Number Publication Date
AU1468792A true AU1468792A (en) 1992-10-21

Family

ID=8094234

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14687/92A Abandoned AU1468792A (en) 1991-03-20 1992-03-18 A composition comprising a peptide for nasal administration

Country Status (5)

Country Link
AU (1) AU1468792A (da)
DK (1) DK49791D0 (da)
MX (1) MX9203615A (da)
WO (1) WO1992016196A1 (da)
ZA (1) ZA922006B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006873A6 (nl) * 1993-03-26 1995-01-10 Merkus Franciscus W H M Toedieningsformulering voor nasale insuline toediening.
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
AU2003257791A1 (en) * 2002-08-15 2004-03-29 Tong Liu Soild nano pharmaceutical formulation and preparation method thereof
EP1643970A2 (en) * 2003-06-09 2006-04-12 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
ES2399053T3 (es) 2004-10-11 2013-03-25 Nasaleze Patents Limited Composiciones para administración intranasal
GB0422582D0 (en) * 2004-10-11 2004-11-10 Nasaleze Patents Ltd Pharmaceutical compositions
WO2006040596A2 (en) * 2004-10-11 2006-04-20 Nasaleze Ppm Limited Compositions for intranasal administration
CA2660029A1 (en) 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
TN2017000349A1 (en) * 2015-02-17 2019-01-16 Lilly Co Eli Nasal powder formulation for treatment of hypoglycemia
TWI771669B (zh) * 2019-04-26 2022-07-21 美商美國禮來大藥廠 製備穩定胜肽調配物之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
EP0200383A3 (en) * 1985-04-15 1987-09-02 Eli Lilly And Company An improved method for administering insulin
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
NL9001681A (nl) * 1990-07-24 1992-02-17 Rijksuniversiteit Transmucosale geneesmiddelpreparaten en transmucosale toediening.

Also Published As

Publication number Publication date
ZA922006B (en) 1992-11-25
WO1992016196A1 (en) 1992-10-01
DK49791D0 (da) 1991-03-20
MX9203615A (es) 1992-09-01

Similar Documents

Publication Publication Date Title
AU5177993A (en) Pharmaceutical compositions containing a calcitonin
AU1219292A (en) Inhaler
AU5945296A (en) Medicament for nasal administration
AU2399092A (en) Aerosol delivery system
AU2421192A (en) Inhaler
AU1218892A (en) Pharmaceutical aerosol formulations
IL99521A0 (en) Nasal pharmaceutical composition
AU7407594A (en) Therapeutic compositions comprising a polypeptide
AU2979092A (en) Single dose dispenser
IL104068A0 (en) Pharmaceutical compositions for inhalation
AU6379294A (en) Nasal pharmaceutical composition containing a progestational agent
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
AU3152993A (en) Improvements in the administration of aerosol compounds
AU4485589A (en) Vaporiser nozzle
ZA922006B (en) A composition comprising a peptide for nasal administration
AU3019292A (en) Pharmaceutical compositions for peroral administration
AU4348493A (en) Inhaler
AU2392492A (en) Pharmaceutical composition
AU6428994A (en) Formulation for nasal insulin delivery
AU2493792A (en) Pharmaceutical preparation
AU3949093A (en) A pharmaceutical formulation
AU2808492A (en) Medicament composition for topical application
AU1500992A (en) Pharmaceutical compound
IL116742A0 (en) Pharmaceutical composition comprising a growth hormone
AU2537992A (en) Pharmaceutical compositions